Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma

Brain Tumor Pathology

Volumn 32, Issue 3, 2015, Pages 176-183

  Saito, Norihiko ^a   Aoki, Kazuya ^a   Hirai, Nozomi ^a   Fujita, Satoshi ^a   Iwama, Junya ^a   Hiramoto, Yu ^a   Ishii, Masashi ^a   Sato, Kenichiro ^a   Nakayama, Haruo ^a   Harashina, Junichi ^a   Hayashi, Morito ^a   Izukura, Hideaki ^a   Kimura, Hitoshi ^a   Ito, Keisuke ^a   Sakurai, Takatoshi ^a   Yokouchi, Yuki ^a   Oharazeki, Toshiaki ^a   Takahashi, Kei ^a   Iwabuchi, Satoshi ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Bevacizumab; Glioma stem cell; Notch; Recurrent glioblastoma

Indexed keywords

BEVACIZUMAB; CD133 ANTIGEN; NOTCH1 RECEPTOR; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NOTCH1 PROTEIN, HUMAN; PEPTIDE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR RECURRENCE; BRAIN NEOPLASMS; CANCER STEM CELL; CELL TRANSFORMATION; COMPARATIVE STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE; YOUNG ADULT;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIGENS, CD; BEVACIZUMAB; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHEMORADIOTHERAPY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PEPTIDES; RECEPTOR, NOTCH1; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84937969442     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-015-0215-7     Document Type: Article

References (42)

1. Chang SM, Theodosopoulos P, Lamborn K et al (2004) Temozolomide in the treatment of recurrent malignant glioma. Cancer 100:605–611
2. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507
3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
4. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
5. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101:781–786
6. Ikushima H, Todo T, Ino Y et al (2010) Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein. J Biol Chem 286:41434–41441
7. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760
8. Liu G, Yuan X, Zeng Z et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
9. Wurmser AE, Nakashima K, Summers RG et al (2004) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430:350–356
10. Bao S, Wu Q, Sathornsumetee S et al (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848
11. Folkins C, Shaked Y, Man S et al (2009) Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 69:7243–7251
12. Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82
13. Gilbertson RJ, Rich JN (2007) Making a tumour’s bed: glioblastoma stem cells and the vascular niche. Nature Rev Cancer 7:733–736
14. Lathia JD, Gallagher J, Heddleston JM et al (2010) Integrin α6 regulates glioblastoma stem cells. Cell Stem Cell 6:421–432
15. Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216–233
16. Fortini ME (2009) Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 16:633–647
17. Kageyama R, Ohtsuka T (1999) The Notch-Hes pathway in mammalian neural development. Cell Res 9:179–188
18. Kanamori M, Kawaguchi T, Nigro JM et al (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106:417–427
19. Purow BW, Haque RM, Noel MW et al (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65:2353–2363
20. Zhu TS, Costello MA, Talsma CE et al (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71:6061–6072
21. Wang J, Wakeman TP, Lathia JD et al (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28:17–28
22. Fan X, Khaki L, Zhu TS et al (2010) Notch pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28:5–16
23. Gilbert CA, Daou MC, Moser RP et al (2010) Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 70:6870–6879
24. Saito N, Fu J, Zheng S et al (2014) A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells 32:301–312
25. Koul D, Jasser SA, Lu Y et al (2002) Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene 21:2357–2364
26. Bao S, Wu Q, Li Z et al (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68:6043–6048
27. Reedijk M, Odorcic S, Zhang H et al (2008) Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 33:1223–1229
28. Liu S, Breit S, Danckwardt S et al (2009) Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines. Ann Hematol 88:613–621
29. Watters JW, Cheng C, Majumder PK et al (2009) De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor model. Cancer Res 69:8949–8957
30. Kageyama R, Ohtsuka T, Hatakeyama J et al (2005) Roles of bHLH genes in neural stem cell differentiation. Exp Cell Res 306:343–348
31. Hatakeyama J, Sakamoto S, Kageyama R (2006) Hes1 and Hes5 regulate the development of the cranial and spinal nerve systems. Dev Neurosci 28:92–101
32. Fan X, Mikolaenko I, Elhassan I et al (2004) Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64:7787–7793
33. Nandhu MS, Hu B, Cole SE et al (2014) Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Cancer Res 74:5435–5448
34. Patenaude A, Fuller M, Chang L et al (2014) Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism. Cancer Res 74:2402–2411
35. Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824–828
36. Bhat KP, Salazar KL, Balasubramaniyan V et al (2011) The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 25:2594–2609
37. Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709–722
38. Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699–708
39. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253–1261
40. Reya T, Morrison SJ, Clarke MF et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
41. Baumann M, Krause M, Hill R et al (2008) Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8:545–554
42. Phillips TM, McBride WH, Pajonk F et al (2006) The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777–1785